Canadian Consensus Recommendations on the Management of <i>MET</i>-Altered NSCLC
In Canada, the therapeutic management of patients with advanced non-small cell lung cancer (NSCLC) with rare actionable mutations differs between provinces, territories, and individual centres based on access to molecular testing and funded treatments. These variations, together with the emergence o...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2021-11-01
|
| Seri Bilgileri: | Current Oncology |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/1718-7729/28/6/386 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|